1. Home
  2. ZNTL vs QNBC Comparison

ZNTL vs QNBC Comparison

Compare ZNTL & QNBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$1.37

Market Cap

165.1M

Sector

Health Care

ML Signal

HOLD

Logo QNB Corp. Common Stock

QNBC

QNB Corp. Common Stock

N/A

Current Price

$46.26

Market Cap

296.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNTL
QNBC
Founded
2014
1877
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
165.1M
296.1M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ZNTL
QNBC
Price
$1.37
$46.26
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $7.44
N/A
AVG Volume (30 Days)
★ 1.3M
76.6K
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
★ 3.37%
EPS Growth
★ 18.03
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.30
$44.75
52 Week High
$6.95
$48.75

Technical Indicators

Market Signals
Indicator
ZNTL
QNBC
Relative Strength Index (RSI) 23.27 42.59
Support Level N/A $45.00
Resistance Level $1.98 $48.75
Average True Range (ATR) 0.18 0.99
MACD -0.01 -0.18
Stochastic Oscillator 8.82 26.15

Price Performance

Historical Comparison
ZNTL
QNBC

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About QNBC QNB Corp. Common Stock

QNB Corp is a bank holding company based in the United States. It operates through its wholly-owned subsidiary, which engages in the general commercial banking business and offers a full range of banking services to its customers. Its business activities involve attracting deposits and using funds in making commercial loans, residential mortgage loans, consumer loans, and purchasing investment securities. The loan portfolio includes commercial loans, such as commercial and industrial, construction, and loans secured by commercial real estate and residential real estate, and retail loans, including home equity loans and lines, and consumer loans. It generates revenue from net interest income.

Share on Social Networks: